Your browser doesn't support javascript.
loading
Impact of opioid maintenance therapy in the community on re-incarceration in individuals with opioid use disorder-A linked cohort study.
Paola, Rosca; Pavel, Spivak; Tatiana, Dudkinski; Hagit, Bonny-Noach; Joseph, Mendlovic; Ronny, Berkovitz; Barak, Shapira.
Afiliación
  • Paola R; Department for the Treatment of Substance Abuse, Israel Ministry of Health, Jerusalem, Israel; Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel.
  • Pavel S; Department for the Treatment of Substance Abuse, Israel Ministry of Health, Jerusalem, Israel.
  • Tatiana D; Department for the Treatment of Substance Abuse, Israel Ministry of Health, Jerusalem, Israel.
  • Hagit BN; Department of Criminology, Ariel University, Ariel, Israel.
  • Joseph M; Israel Ministry of Health, Jerusalem, Israel; Department of Pediatrics, Shaare Zedek Medical Center, affiliated with Haddasah-Hebrew University School of Medicine, Jerusalem, Israel.
  • Ronny B; Division of Enforcement and Inspection, Israel Ministry of Health, Jerusalem, Israel.
  • Barak S; Israel Ministry of Health, Jerusalem, Israel. Electronic address: barak.shapira@moh.gov.il.
J Subst Use Addict Treat ; 163: 209393, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38754555
ABSTRACT

INTRODUCTION:

Studies have found associations between Opioid Agonist Maintenance Treatment during incarceration and reduced recidivism among recently released formerly incarcerated persons. However, the role of community-based Opioid Agonist Maintenance Treatment in reducing recidivism post-release remains less explored. This study examines whether pre-release arranged, prison-to-rehabilitation Opioid Agonist Maintenance Treatment in the community following release is associated with reduced rates and lengths of re-incarceration among justice-involved individuals with Opioid Use Disorder.

METHODS:

A retrospective matched cohort study was conducted using linked records of 208 individuals with a history of Opioid Use Disorder and treatment during their incarceration. The primary predictor variable was the duration of Opioid Agonist Maintenance Treatment, with re-incarceration rates and lengths of stay after re-incarceration being the primary outcomes examined.

RESULTS:

Analysis showed a significant decrease in re-incarcerations and or lengths of stay in prison among those who have been re-incarcerated and have undergone Opioid Agonist Maintenance Treatment in the community for >24 months.

CONCLUSIONS:

Maintaining Opioid Agonist Maintenance Treatment over 24 months may reduce re-incarcerations, and may be significantly associated with a reduction in the length of prison stay for re-incarcerated individuals. The effects were consistent across the overall population and the individuals receiving the treatment. Various other unmeasured factors, including judicial discretion, individual motivation, type of offense, and employment status, could influence this association.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prisioneros / Tratamiento de Sustitución de Opiáceos / Trastornos Relacionados con Opioides Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: J Subst Use Addict Treat Año: 2024 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prisioneros / Tratamiento de Sustitución de Opiáceos / Trastornos Relacionados con Opioides Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: J Subst Use Addict Treat Año: 2024 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos